Overview of Dr. Wolchok
Dr. Jedd Wolchok is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center. He received his medical degree from New York University Grossman School of Medicine and has been in practice 29 years. He is one of 503 doctors at Memorial Sloan Kettering Cancer Center and one of 370 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
1305 York Ave., 12th Floor
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 2000
New York University School of MedicineResidency, 1994 - 1997- New York University School of MedicineClass of 1994
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 1995 - 2026
NJ State Medical License 2018 - 2025
NC State Medical License 2020 - 2022
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsRNA neoantigen vaccines prime long-lived CD8T cells in pancreatic cancer.Zachary Sethna, Pablo Guasp, Charlotte Reiche, Martina Milighetti, Nicholas Ceglia
Nature. 2025-03-01 - Host tissue factors predict immune surveillance and therapeutic outcomes in gastric cancer.Miseker Abate, Emily Stroobant, Teng Fei, Ya-Hui Lin, Shoji Shimada
Cancer Immunology Research. 2025-01-09 - 35 citationsFinal, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.Jedd D Wolchok, Vanna Chiarion-Sileni, Piotr Rutkowski, C Lance Cowey, Dirk Schadendorf
The New England Journal of Medicine. 2025-01-02
Press Mentions
Breakthrough mRNA Vaccine Reinvents Pancreatic Cancer TreatmentMarch 20th, 2025- Groundbreaking mRNA Vaccine Revolutionizes Pancreatic Cancer TreatmentJanuary 5th, 2025
- New Starr Cancer Consortium Grants Awarded to Weill Cornell Medicine ResearchersOctober 30th, 2024
- Join now to see all
Grant Support
- Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapiesWEILL MEDICAL COLL OF CORNELL UNIV2025–2030
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
